Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: A4H6S6
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 13 |
GO:0003677 | DNA binding | 4 | 13 |
GO:0005488 | binding | 1 | 13 |
GO:0097159 | organic cyclic compound binding | 2 | 13 |
GO:1901363 | heterocyclic compound binding | 2 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 61 | 65 | PF00656 | 0.485 |
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.648 |
CLV_NRD_NRD_1 | 204 | 206 | PF00675 | 0.677 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.401 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.642 |
CLV_PCSK_KEX2_1 | 188 | 190 | PF00082 | 0.669 |
CLV_PCSK_KEX2_1 | 204 | 206 | PF00082 | 0.658 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.397 |
CLV_PCSK_PC1ET2_1 | 188 | 190 | PF00082 | 0.673 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 240 | 244 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.367 |
DEG_APCC_DBOX_1 | 221 | 229 | PF00400 | 0.494 |
DOC_CDC14_PxL_1 | 141 | 149 | PF14671 | 0.587 |
DOC_CYCLIN_RxL_1 | 204 | 216 | PF00134 | 0.634 |
DOC_CYCLIN_RxL_1 | 42 | 54 | PF00134 | 0.369 |
DOC_PP1_RVXF_1 | 135 | 142 | PF00149 | 0.656 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.391 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.676 |
DOC_USP7_UBL2_3 | 263 | 267 | PF12436 | 0.568 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.402 |
DOC_WW_Pin1_4 | 59 | 64 | PF00397 | 0.492 |
LIG_14-3-3_CanoR_1 | 103 | 111 | PF00244 | 0.377 |
LIG_14-3-3_CanoR_1 | 247 | 255 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 25 | 29 | PF00244 | 0.406 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.635 |
LIG_deltaCOP1_diTrp_1 | 33 | 37 | PF00928 | 0.397 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.673 |
LIG_FHA_1 | 175 | 181 | PF00498 | 0.594 |
LIG_FHA_1 | 209 | 215 | PF00498 | 0.495 |
LIG_LIR_Gen_1 | 64 | 74 | PF02991 | 0.500 |
LIG_LIR_Gen_1 | 89 | 100 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 138 | 144 | PF02991 | 0.602 |
LIG_LIR_Nem_3 | 285 | 289 | PF02991 | 0.488 |
LIG_LIR_Nem_3 | 33 | 37 | PF02991 | 0.384 |
LIG_LIR_Nem_3 | 64 | 70 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 89 | 95 | PF02991 | 0.388 |
LIG_PTB_Apo_2 | 115 | 122 | PF02174 | 0.386 |
LIG_SH2_GRB2like | 126 | 129 | PF00017 | 0.500 |
LIG_SH2_PTP2 | 45 | 48 | PF00017 | 0.415 |
LIG_SH2_PTP2 | 67 | 70 | PF00017 | 0.500 |
LIG_SH2_STAP1 | 284 | 288 | PF00017 | 0.592 |
LIG_SH2_STAT5 | 284 | 287 | PF00017 | 0.588 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.382 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.629 |
LIG_SUMO_SIM_anti_2 | 223 | 229 | PF11976 | 0.607 |
LIG_SUMO_SIM_par_1 | 210 | 216 | PF11976 | 0.568 |
LIG_SUMO_SIM_par_1 | 223 | 229 | PF11976 | 0.589 |
LIG_TRAF2_1 | 184 | 187 | PF00917 | 0.564 |
LIG_TRAF2_1 | 54 | 57 | PF00917 | 0.502 |
MOD_CDC14_SPxK_1 | 119 | 122 | PF00782 | 0.402 |
MOD_CDK_SPxK_1 | 116 | 122 | PF00069 | 0.402 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.628 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.402 |
MOD_CK2_1 | 51 | 57 | PF00069 | 0.498 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.460 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.550 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.400 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.362 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.630 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.395 |
MOD_LATS_1 | 245 | 251 | PF00433 | 0.491 |
MOD_N-GLC_1 | 35 | 40 | PF02516 | 0.502 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.377 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.386 |
MOD_NEK2_1 | 277 | 282 | PF00069 | 0.501 |
MOD_PIKK_1 | 102 | 108 | PF00454 | 0.402 |
MOD_PKA_2 | 102 | 108 | PF00069 | 0.377 |
MOD_PKA_2 | 24 | 30 | PF00069 | 0.415 |
MOD_Plk_1 | 137 | 143 | PF00069 | 0.652 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.402 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.402 |
MOD_ProDKin_1 | 59 | 65 | PF00069 | 0.492 |
MOD_SUMO_for_1 | 192 | 195 | PF00179 | 0.468 |
TRG_DiLeu_BaEn_1 | 223 | 228 | PF01217 | 0.609 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.415 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.428 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.283 |
TRG_ER_diArg_1 | 166 | 168 | PF00400 | 0.656 |
TRG_ER_diArg_1 | 189 | 192 | PF00400 | 0.664 |
TRG_ER_diArg_1 | 203 | 205 | PF00400 | 0.663 |
TRG_NES_CRM1_1 | 223 | 237 | PF08389 | 0.504 |
TRG_Pf-PMV_PEXEL_1 | 183 | 187 | PF00026 | 0.647 |
TRG_Pf-PMV_PEXEL_1 | 204 | 208 | PF00026 | 0.600 |
TRG_Pf-PMV_PEXEL_1 | 222 | 226 | PF00026 | 0.551 |
TRG_Pf-PMV_PEXEL_1 | 47 | 51 | PF00026 | 0.364 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5T3 | Leptomonas seymouri | 85% | 99% |
A0A0S4JCN1 | Bodo saltans | 26% | 90% |
A0A0S4JLV2 | Bodo saltans | 52% | 100% |
A0A1X0NMT4 | Trypanosomatidae | 69% | 99% |
A0A3R7KK47 | Trypanosoma rangeli | 68% | 99% |
A0A3S5H6K3 | Leishmania donovani | 93% | 100% |
A4HV54 | Leishmania infantum | 92% | 99% |
C9ZQD1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 99% |
E9ANT7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QGT3 | Leishmania major | 92% | 100% |
V5BHW6 | Trypanosoma cruzi | 66% | 99% |